OTC Pharmaceuticals - Kenya | Statista Market Forecast

Revenue in the OTC Pharmaceuticals market amounts to US$373.60m in 2024. The market is expected to grow annually by 7.36% (CAGR 2024-2029).
The market's largest segment is the segment Vitamins & Minerals with a market volume of US$177.90m in 2024.
In global comparison, most revenue is generated United States (US$41bn in 2024).
In relation to total population figures, per person revenues of US$6.65 are generated in 2024.
In the OTC Pharmaceuticals market, 1.4% of total revenue will be generated through online sales by 2024.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Kenya is experiencing significant growth and development due to various factors.

Customer preferences: Customers in Kenya have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors. Firstly, OTC medications offer convenience and accessibility, allowing customers to self-diagnose and self-treat common ailments without the need for a doctor's prescription. This is particularly appealing in a country where access to healthcare services may be limited in certain areas. Additionally, OTC medications are often more affordable compared to prescription drugs, making them a more viable option for many Kenyan consumers.

Trends in the market: One trend in the OTC Pharmaceuticals market in Kenya is the increasing demand for herbal and natural remedies. Kenyan consumers have a long history of using traditional herbal medicines, and this trend has extended to the OTC market. Many consumers are seeking alternative and natural remedies for common ailments, such as herbal teas for digestion or herbal ointments for pain relief. This trend is driven by a growing interest in holistic health and wellness, as well as a desire for products with fewer side effects. Another trend in the market is the rising popularity of online pharmacies and e-commerce platforms. With the increasing penetration of smartphones and internet connectivity in Kenya, more consumers are turning to online channels to purchase OTC medications. Online pharmacies offer a wide range of products, competitive prices, and the convenience of home delivery. This trend is expected to continue as more Kenyan consumers embrace digital technologies and online shopping.

Local special circumstances: One of the unique aspects of the OTC Pharmaceuticals market in Kenya is the presence of informal markets and street vendors. These informal channels play a significant role in the distribution of OTC medications, particularly in rural areas where formal pharmacies may be scarce. Street vendors often sell OTC medications alongside other products, such as food or household items, making them easily accessible to consumers. While this informal sector provides convenience and affordability, it also poses challenges in terms of quality control and regulatory oversight.

Underlying macroeconomic factors: The growth of the OTC Pharmaceuticals market in Kenya is also influenced by underlying macroeconomic factors. Kenya has experienced steady economic growth in recent years, resulting in an expanding middle class with higher disposable incomes. This has led to increased consumer spending on healthcare products, including OTC medications. Additionally, the government has implemented policies to improve healthcare access and affordability, further driving the demand for OTC pharmaceuticals. In conclusion, the OTC Pharmaceuticals market in Kenya is growing and evolving due to customer preferences for convenience and affordability, as well as the increasing popularity of herbal remedies and online channels. The presence of informal markets and the country's macroeconomic factors also contribute to the development of the market. As Kenya continues to experience economic growth and advancements in healthcare, the OTC Pharmaceuticals market is expected to expand further in the coming years.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Consumer market, in a PDF format.

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.